ARCTURUS THERAPEUTICS HLDGS's ticker is ARCT and the CUSIP is 03969T109. A total of 133 filers reported holding ARCTURUS THERAPEUTICS HLDGS in Q1 2022. The put-call ratio across all filers is 0.54 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,468,767 | +21.9% | 57,486 | +36.8% | 0.01% | +16.7% |
| Q2 2023 | $1,204,761 | +3.7% | 42,007 | +33.8% | 0.01% | 0.0% |
| Q4 2021 | $1,162,000 | -49.5% | 31,396 | -34.8% | 0.01% | -60.0% |
| Q3 2021 | $2,301,000 | -68.7% | 48,161 | -77.8% | 0.02% | -70.6% |
| Q2 2021 | $7,341,000 | -38.5% | 216,923 | -24.9% | 0.05% | -41.4% |
| Q1 2021 | $11,931,000 | +448.3% | 288,879 | +476.0% | 0.09% | +383.3% |
| Q4 2020 | $2,176,000 | – | 50,151 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Green Alpha Advisors, LLC | 8,394 | $264,663 | 0.19% |
| Global Wealth Strategies & Associates | 100 | $3,153 | 0.00% |